Vaccine Programs
Technology and products provide much-needed solutions to medical needs in animal health, including reducing antibiotic use.
Product Pipeline
The vaccines of the pipeline target quickly mutating pathogens, such as bluetongue virus type 3 (BTV-3). There is a growing demand for adaptable, fast-to-market vaccines in this multi-billion market. Each program aims at First-to-market or First-in-Class in their respective target markets. The Unified Vaccine Platform provides high development productivity, allowing the start of new programs at a high frequency.
The Unified Vaccine Platform provides significant customer benefits across the entire value chain, i.e. from initial vaccine generation to standardized development to ‘same for all’ industrial manufacturing under GMP. The platform has been thoroughly validated and de-risked in 7 vaccine programs with a variety of pathogens.
